Yahoo · Oct 23, 2026
BC-Most Active Stocks
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks:Stock Name Volume High Low Last Change 22nd Century Group Inc.
LU
NASDAQ · LUCD
Lucid Diagnostics Inc. Common Stock
Healthcare · Medical - Devices
$0.41
Up+$0.04 (+10.78%)
Updated Nov 4, 2026, 7:53 PM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 117.03M
- P/E ratio
- -2.06
- Dividend yield
- 0.00%
- 52-week range
- $0.30 – $1.63
- Volume
- 1.62M
- Avg. volume
- 939.24K
Price performance · LUCD
LUCD price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
LUCD closed at $0.41 after 21 trading sessions, down 31.83% for the selected period.
- Last close
- $0.41
- Period change
- -31.83%
- Period low
- $0.33
- Period high
- $0.65
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $0.40 | $0.4343 | $0.396 | $0.409 | 1.62M |
| Nov 2, 2026 | $0.405 | $0.4109 | $0.393 | $0.4063 | 1.35M |
| Oct 30, 2026 | $0.4145 | $0.44 | $0.4031 | $0.4048 | 1.71M |
| Oct 29, 2026 | $0.4116 | $0.4563 | $0.403 | $0.4323 | 5.06M |
| Oct 28, 2026 | $0.4376 | $0.44 | $0.38 | $0.4116 | 6.33M |
| Oct 27, 2026 | $0.52 | $0.5456 | $0.415 | $0.4381 | 10.24M |
| Oct 26, 2026 | $0.416 | $0.56 | $0.4059 | $0.5007 | 43.58M |
| Oct 23, 2026 | $0.4341 | $0.4525 | $0.388 | $0.411 | 111.8M |
| Oct 22, 2026 | $0.321 | $0.33 | $0.303 | $0.3277 | 48.1M |
| Oct 21, 2026 | $0.36 | $0.3925 | $0.3209 | $0.3334 | 3.69M |
| Oct 20, 2026 | $0.3683 | $0.3748 | $0.3033 | $0.3519 | 6.33M |
| Oct 19, 2026 | $0.4802 | $0.4802 | $0.3583 | $0.3774 | 4.27M |
| Oct 16, 2026 | $0.5224 | $0.5255 | $0.4702 | $0.478 | 2.34M |
| Oct 15, 2026 | $0.5442 | $0.5687 | $0.51 | $0.5201 | 3.01M |
| Oct 14, 2026 | $0.591 | $0.6177 | $0.5401 | $0.5431 | 1.82M |
| Oct 13, 2026 | $0.60 | $0.6198 | $0.5768 | $0.606 | 1.1M |
| Oct 12, 2026 | $0.6315 | $0.66 | $0.5974 | $0.5974 | 1.64M |
| Oct 9, 2026 | $0.65 | $0.6897 | $0.6205 | $0.638 | 1.95M |
| Oct 8, 2026 | $0.61 | $0.6743 | $0.6034 | $0.6501 | 2.51M |
| Oct 7, 2026 | $0.591 | $0.653 | $0.5875 | $0.6235 | 1.71M |
| Oct 6, 2026 | $0.60 | $0.6107 | $0.58 | $0.60 | 1.46M |
Latest LUCD news
The latest Smart Investors Daily articles mentioning LUCD.
Stock researchCompany · Overview
Company
Market Activity
Research & News
LUCD research
Overview
Company profile and research snapshot.
Company profile
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $2.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 23, 2026 | BTIG | Buy | — |
| Aug 27, 2026 | Ascendiant Capital | Buy | — |
| Aug 17, 2026 | BTIG | Buy | — |
| Jun 8, 2026 | Ascendiant Capital | Buy | — |
| May 15, 2026 | Maxim Group | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Oct 23, 2026
BTIG Reiterates Buy on Lucid Diagnostics, Maintains $2.5 Price Target
BTIG analyst Mark Massaro reiterates Lucid Diagnostics (NASDAQ:LUCD) with a Buy and maintains $2.5 price target.
Benzinga · Oct 1, 2026
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Elutia (NASDAQ:ELUT) stock moved upwards by 17.2% to $0.94 during Thursday's after-market session. The market value of their outstanding shares is at $34.9 million. Intelligent Bio Solutions (NASDAQ:INBS)
ChartMill · Oct 1, 2026
Which stocks are experiencing notable movement on Thursday?
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
